PROTHROMPLEX
Live / Applied — Fifth extension granted (statement of use) (as of 24 Jan 2026)
What this means for you
Not registered yet, but its 26 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97239683
- Mark type
- Stylized text
- Filed
- 26 Jan 2022
- Published for opposition
- 31 Jan 2023
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, blood plasma protein that is converted into thrombin during blood clotting
Owner
- Baxalta Incorporated, Bannockburn, IL, US
- Baxalta Incorporated, Bannockburn, IL, US
Prosecution history
- 25 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jan 2026 — SOU EXTENSION 5 GRANTED
- 04 Sept 2025 — SOU EXTENSION 5 FILED
- 24 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2024 — SOU EXTENSION 4 GRANTED
- 16 Dec 2024 — SOU EXTENSION 4 FILED
- 16 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Aug 2024 — SOU EXTENSION 3 GRANTED
- 06 Aug 2024 — SOU EXTENSION 3 FILED
- 06 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 08 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2024 — SOU EXTENSION 2 GRANTED